|
|
| Enabling Subcutaneous Delivery For Improved Patient Compliance | The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens. Discover how Nanoform Biologics’ innovative approach to high-dose subcutaneous delivery of biologics addresses the challenges of traditional SC delivery methods. |
|
|
|
|
| Constraints And Solutions For Biopharmaceutical Manufacturing | Article | By Scott Merz, Asahi Kasei Bioprocess | Dissect the reasons for capacity bottlenecks stemming from process development scope, downstream chromatography, and equipment constraints, and delve into the potential solutions associated with each. |
|
|
|
|
|
| Strategies For Achieving Regulatory Milestones Faster | Webinar | Quotient Sciences | Discover how a vendor that offers integrated drug substance, drug product, and clinical testing activities under one organization facilitates improved communication and a more agile approach to development. |
|
|
| Optimizing CMO Partnerships | Q&A | SMC Ltd. | SMC experts discuss best practices and tips across a range of topics, which include program management, automation, and secondary services. |
|
|
|
|
|
|
| Detection Of Low Bacterial Contamination With ICR Swabs | Application Note | MilliporeSigma | See how a study was designed to prove the suitability of ICR Swabs and lockable TSA w. LTHThio contact plates to detect low numbers of different bacterial test strains from Neoprene® gloves. |
|
|
| Solutions For Accelerated Pharmaceutical Development | Article | By David K. Lyon, Ph.D., and Conrad Roten, Ph.D., Lonza | Uncover an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties, such as low aqueous solubility and poor bioavailability. |
|
|
|
|
|
| Whether you're breaking ground on a brand-new manufacturing facility or looking to upgrade an existing site, there are a dizzying number of considerations. Join Pharmaceutical Online Live on Wednesday, April 16th for a digital panel discussion on key factors in facility design, from construction sequencing to site validation. Registration is free thanks to the support of AES. |
|
|
|
|
By David Shenberger, Belay Station Advisors | Few life sciences companies are ready for a disaster, particularly a cyber one. Key factors include an integrated approach to cyber preparedness and risk planning, a dedicated team, and more. | |
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|